JPS563000Y2 - - Google Patents

Info

Publication number
JPS563000Y2
JPS563000Y2 JP10051576U JP10051576U JPS563000Y2 JP S563000 Y2 JPS563000 Y2 JP S563000Y2 JP 10051576 U JP10051576 U JP 10051576U JP 10051576 U JP10051576 U JP 10051576U JP S563000 Y2 JPS563000 Y2 JP S563000Y2
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP10051576U
Other languages
Japanese (ja)
Other versions
JPS5318894U (ru
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to JP10051576U priority Critical patent/JPS563000Y2/ja
Publication of JPS5318894U publication Critical patent/JPS5318894U/ja
Application granted granted Critical
Publication of JPS563000Y2 publication Critical patent/JPS563000Y2/ja
Expired legal-status Critical Current

Links

JP10051576U 1976-07-27 1976-07-27 Expired JPS563000Y2 (ru)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP10051576U JPS563000Y2 (ru) 1976-07-27 1976-07-27

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP10051576U JPS563000Y2 (ru) 1976-07-27 1976-07-27

Publications (2)

Publication Number Publication Date
JPS5318894U JPS5318894U (ru) 1978-02-17
JPS563000Y2 true JPS563000Y2 (ru) 1981-01-23

Family

ID=28710763

Family Applications (1)

Application Number Title Priority Date Filing Date
JP10051576U Expired JPS563000Y2 (ru) 1976-07-27 1976-07-27

Country Status (1)

Country Link
JP (1) JPS563000Y2 (ru)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9359395B2 (en) 2009-02-05 2016-06-07 Tokai Pharmaceuticals, Inc. Prodrugs of steroidal CYP17 inhibitors/antiandrogens
US9387216B2 (en) 2013-08-12 2016-07-12 Tokai Pharmaceuticals, Inc. Biomarkers for treatment of neoplastic disorders using androgen-targeted therapies
US9439912B2 (en) 2013-03-14 2016-09-13 University Of Maryland, Baltimore Androgen receptor down-regulating agents and uses thereof

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS59205538A (ja) * 1983-05-10 1984-11-21 Yanmar Diesel Engine Co Ltd 屋内通路のエア・カ−テン装置
JP4349124B2 (ja) * 2003-12-25 2009-10-21 大成建設株式会社 加圧防煙システム
EP2598718B1 (en) * 2010-07-27 2014-06-25 Josip Pavetic Method and system for tunnel ventilation in normal conditions and in conditions of fire
JP5891824B2 (ja) * 2012-02-02 2016-03-23 株式会社大林組 通路状空間の排煙設備
JP6323083B2 (ja) * 2014-03-11 2018-05-16 株式会社大林組 加圧防排煙設備

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9359395B2 (en) 2009-02-05 2016-06-07 Tokai Pharmaceuticals, Inc. Prodrugs of steroidal CYP17 inhibitors/antiandrogens
US9439912B2 (en) 2013-03-14 2016-09-13 University Of Maryland, Baltimore Androgen receptor down-regulating agents and uses thereof
US9387216B2 (en) 2013-08-12 2016-07-12 Tokai Pharmaceuticals, Inc. Biomarkers for treatment of neoplastic disorders using androgen-targeted therapies

Also Published As

Publication number Publication date
JPS5318894U (ru) 1978-02-17

Similar Documents

Publication Publication Date Title
FR2368434B1 (ru)
BR5601547U (ru)
CS178382B1 (ru)
CS177747B1 (ru)
CS176997B1 (ru)
CH604136A5 (ru)
CH603076A5 (ru)
CH585144A5 (ru)
CH609496A5 (ru)
CH593489A5 (ru)
CH593754A5 (ru)
CH594137A5 (ru)
CH595821A5 (ru)
CH596520A5 (ru)
CH597018A5 (ru)
CH597780A5 (ru)
CH599440A5 (ru)
CH600027A5 (ru)
CH600965A5 (ru)
CH602857A5 (ru)
DD125145A1 (ru)
CH603210A5 (ru)
CH610953A5 (ru)
CH604036A5 (ru)
DD125094A5 (ru)